• Guideline Summary
  • NGC:011000
  • 2016 Apr

Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for UGT1A1 and atazanavir prescribing.

  • Guideline Summary
  • NGC:010944
  • 2015 Sep 18

Therapeutic drug monitoring of vancomycin: a guideline of the Division of Therapeutic Drug Monitoring, Chinese Pharmacological Society.

  • Guideline Summary
  • NGC:010186
  • 2010 Mar (revised 2013 Nov)

Neuropathic pain - pharmacological management. The pharmacological management of neuropathic pain in adults in non-specialist settings.

  • Guideline Summary
  • NGC:010403
  • 2011 Jan 28 (revised 2014)

Preexposure prophylaxis for the prevention of HIV Infection in the United States - 2014.

  • Guideline Summary
  • NGC:009587
  • 2012 Apr (reaffirmed 2014)

Clinical Pharmacogenetics Implementation Consortium guidelines for HLA-B genotype and abacavir dosing.

  • Guideline Summary
  • NGC:009348
  • 2012

Standardizing central venous catheter care: hospital to home.

  • Guideline Summary
  • NGC:011099
  • 2016 Jul 29

U.S. selected practice recommendations for contraceptive use, 2016.

  • Guideline Summary
  • NGC:011091
  • 2016 Jul 29

U.S. medical eligibility criteria for contraceptive use, 2016.

  • Guideline Summary
  • NGC:010331
  • 2014 Feb

Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for IFNL3 (IL28B) genotype and PEG interferon-α–based regimens.

Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection.

  • Guideline Summary
  • NGC:009207
  • 2012 Apr

Human immunodeficiency virus type 2 (HIV-2).